Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02353351 · ClinicalTrials.gov registry record
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
A clinical trial, sponsored by Abbott Medical Devices.
- Terminated
- Registry status
- 602
- Enrollment target
NCT02353351 is a clinical trial that was terminated before completion, run by Abbott Medical Devices. The registered enrollment target is 602 participants.
The verdict
NCT02353351 was terminated before completion, sponsored by Abbott Medical Devices.
- TERMINATED
- Registry status
- 602 participants
- Enrollment target
Study Summary
Prospective, multicenter, case-cohort study.To identify potential risk factors associated with the occurrence of erosion due to implantation of the AMPLATZER™ Septal Occluder (ASO.)
Interventions
- DEVICE atrial septal occluder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 602 participants |
| Start Date | 2015-01-19 |
| Est. Completion | 2017-02-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02353351
The ClinicalTrials.gov registry entry for NCT02353351 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 602 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which atrial septal occluder is the first listed.
NCT02353351 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02353351 about?
NCT02353351 is a clinical study titled "ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study". Prospective, multicenter, case-cohort study.To identify potential risk factors associated with the occurrence of erosion due to implantation of the AMPLATZER™ Septal Occluder (ASO.)
What is the current status of trial NCT02353351?
This trial is currently terminated. The enrollment target is 602 participants. The study started on 2015-01-19. Estimated completion is 2017-02-24.
What interventions are being tested in trial NCT02353351?
The interventions under investigation include: atrial septal occluder (DEVICE).
Who is sponsoring clinical trial NCT02353351?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.